Last reviewed · How we verify

Colesevelam hydrochloride film-coated tablets

Genzyme, a Sanofi Company · FDA-approved active Small molecule Quality 0/100

Colesevelam hydrochloride film-coated tablets is a Small molecule drug developed by Genzyme, a Sanofi Company. It is currently FDA-approved. Also known as: Cholestagel.

Colesevelam hydrochloride, marketed by Genzyme, a Sanofi Company, is an established drug in the pharmaceutical market with a key composition patent expiring in 2028. Its primary strength lies in its well-established market presence and the extended patent protection, which helps maintain its competitive edge. The primary risk is the potential increase in competition following the patent expiry in 2028.

At a glance

Generic nameColesevelam hydrochloride film-coated tablets
Also known asCholestagel
SponsorGenzyme, a Sanofi Company
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Colesevelam hydrochloride film-coated tablets

What is Colesevelam hydrochloride film-coated tablets?

Colesevelam hydrochloride film-coated tablets is a Small molecule drug developed by Genzyme, a Sanofi Company.

Who makes Colesevelam hydrochloride film-coated tablets?

Colesevelam hydrochloride film-coated tablets is developed and marketed by Genzyme, a Sanofi Company (see full Genzyme, a Sanofi Company pipeline at /company/genzyme-a-sanofi-company).

Is Colesevelam hydrochloride film-coated tablets also known as anything else?

Colesevelam hydrochloride film-coated tablets is also known as Cholestagel.

What development phase is Colesevelam hydrochloride film-coated tablets in?

Colesevelam hydrochloride film-coated tablets is FDA-approved (marketed).

Related